KRAS and non-small cell lung carcinoma: Among 713 non-squamous NSCLC lacking EGFR/KRAS/HER2/BRAF/PI3KCA/ALK aberrations, we reported 2.1% and 2.5% ROS1 and RET rearrangements, respectively.